August 11, 2025 · Form 4 insider transaction
HOMCY CHARLES J sold 50,000 shares of BridgeBio Pharma, Inc. at $48.00 per share, a transaction worth $2.40M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 8, 2025.